Aim Rule 26
The information below has been disclosed pursuant to Rule 26 of the AIM Rules for Companies.
This page was last updated on 25 August 2021
Description of the business
Please click here for a description of the business.
The names of the directors and biographical details
Please click here for the details of Evgen Pharma’s directors.
Please click here for the directors’ responsibilities.
Country of incorporation and main country of operation
Evgen Pharma plc is incorporated and registered in England and Wales with registered number 09246681. Its main country of operation is the United Kingdom. Evgen Pharma plc is subject to the UK City Code on Takeovers and Mergers.
Current constitutional documents
Please click here for the Articles of Association.
Number of securities in issue
The number of ordinary shares in issue is 274,888,117 all of which are in public hands. The Company does not hold any shares in Treasury. Please see here for a list of significant shareholders.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Please click here for annual and half yearly reports.
Please click here for news notifications.
Admission document and circulars
Please click here for the Admission Document.
Please click here for the Circular dated 8 December 2017.
Please click here for the Circular dated 18 April 2019.
Please click here for the Circular dated 12 February 2021.
Please click here for details of Evgen Pharma’s nominated adviser and other key advisers.